CoChat

A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse

Covey, Lirio S., Glassman, Alexander H., Jiang, Huiping, Fried, Jane, Masmela, Jenny, LoDuca, Catherine, Petkova, Eva, Rodriguez, Kristina · 2007 · Addiction
Cited by 49

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Aim To investigate the efficacy of maintenance treatment with bupropion and/or nicotine gum for reducing smoking relapse. Design, setting and participants A 48‐week study was conducted at a university‐based smoking cessation clinic between February 2001 and October 2005. A total of 588 smokers received bupropion and nicotine patch in 8 weeks of open‐label treatment (OLT); 289 abstainers during the last 4 weeks of OLT were randomized in double‐blind placebo‐controlled fashion to one of four arms for 16 weeks of maintenance treatment (MT) followed by 24 weeks of non‐treatment follow‐up (NTFU). Intervention Bupropion (300 mg/day) and 2 mg nicotine gum, used alone or combined, and comparable placebo pill and placebo gum. Behavioral counseling at all visits. Outcome Time to relapse (TTR) from randomization. Relapse is defined as the first 7 consecutive days of smoking. Abstinence verified by carbon monoxide ≤ 8 parts per million. Findings TTR was longer with extended active treatments compared to placebo (median days to relapse: bupropion + placebo = 136, nicotine + placebo = 98, bupropion + nicotine = 90, double placebo = 71). Hazard ratios (HR) for relapse were statistically significant for bupropion + placebo versus double placebo during MT (HR = 0.59, 95% CI = 0.37–0.92) and to the end of NTFU (HR = 0.66, 95% CI = 0.42–0.96). However, bupropion's advantage dissipated upon stopping the drug. Gum use was low, preventing a valid assessment; but analysis restricted to gum users suggested a weak effect of extended nicotine gum. Conclusion Maintenance treatment with bupropion exerted a modest benefit for preventing smoking relapse; the optimum duration of bupropion treatment was unclear. Further research is needed to ascertain the merits of extended use of nicotine gum, other nicotine replacement agents and other treatments known to aid smokers for preventing relapse once abstinence is achieved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1360-0443.2007.01887.x

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 49

Metadata

Authors
Covey, L. S., Glassman, A. H., Jiang, H., Fried, J., Masmela, J., LoDuca, C., Petkova, E., & Rodriguez, K.
Venue
Addiction
Publisher
Wiley
Published
2007-07-06
Volume
102
Issue
8
Pages
1292-1302
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W2066452008
Cited by
49
References
12
FWCI
3.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. https://app.cochat.ai/papers/10.1111/j.1360-0443.2007.01887.x
The paper
Covey, L. S., Glassman, A. H., Jiang, H., Fried, J., Masmela, J., LoDuca, C., Petkova, E., & Rodriguez, K. (2007). A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. Addiction. https://doi.org/10.1111/j.1360-0443.2007.01887.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.